We evaluated the major intestinal barrier indicators, and it has been reported that the expression of ZO-1, an intestinal barrier indicator, was significantly suppressed in the colon of NAFLD (Zhang et al., 2022). The gene discussed is TJP1; the disease is metabolic dysfunction-associated steatotic liver disease.